Site Basel, under the lead of Prof. Dr. med. Dirk Fischer, started the recruitment process successfully on 11th of June, 2018.
Site Berlin, Site Essen, Site Barcelona, Site Sevilla, Site Liverpool, Site Leeds, Site Glasgow, Site Nijmegen, Site Bruxelles and Site Strassbourg have also successfully started with the recruitment process.
The TAMDMD Open Label Extension is planned at all TAMDMD Sites and has already been approved at Site Basel, where the first patients entered the Open Label Extension in June 2019.